Construction of chimeric vaccinia viruses by molecular cloning and packaging
- PMID: 1438247
- PMCID: PMC50260
- DOI: 10.1073/pnas.89.21.9977
Construction of chimeric vaccinia viruses by molecular cloning and packaging
Abstract
Foreign DNA was inserted into unique restriction endonuclease cleavage sites (Sma I or Not I) of the 200,000-base-pair vaccinia virus genome by direct molecular cloning. The modified vaccinia virus DNA was packaged in fowlpox virus-infected avian cells, and chimeric vaccinia virus was isolated from mammalian cells not supporting the growth of the fowlpox helper virus. In contrast to the classical "in vivo" recombination technique, chimeric viruses with inserts in both possible orientations and families of chimeras with multiple inserts were obtained. The different genomic configurations of chimeric viruses provide a broader basis for screening of optimal viruses. In addition to packaging in avian cells, a second packaging procedure for vaccinia DNA, based on the abortive infection of mammalian cells with the fowlpox helper virus, was developed. This procedure permits simultaneous packaging and host-range selection for the packaged virus. The cloning/packaging procedure allows the direct insertion of foreign DNA without the need for plasmids having flanking regions homologous to viral nonessential regions and is independent of inefficient in vivo recombination events. By direct cloning and packaging, about 5-10% of the total vaccinia virus yield consisted of chimeras. The procedure is, therefore, a useful tool in molecular virology.
Similar articles
-
Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene.J Virol. 1990 Feb;64(2):527-33. doi: 10.1128/JVI.64.2.527-533.1990. J Virol. 1990. PMID: 2153222 Free PMC article.
-
A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts.J Gen Virol. 1995 Dec;76 ( Pt 12):2957-62. doi: 10.1099/0022-1317-76-12-2957. J Gen Virol. 1995. PMID: 8847500
-
Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors.Virology. 1992 Sep;190(1):522-6. doi: 10.1016/0042-6822(92)91246-q. Virology. 1992. PMID: 1529553
-
Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.Methods Mol Biol. 2004;269:31-40. doi: 10.1385/1-59259-789-0:031. Methods Mol Biol. 2004. PMID: 15114005 Review.
-
Vaccinia viral/retroviral chimeric vectors.Curr Gene Ther. 2004 Dec;4(4):417-26. doi: 10.2174/1566523043346101. Curr Gene Ther. 2004. PMID: 15578991 Review.
Cited by
-
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.Res Sq [Preprint]. 2020 Jul 17:rs.3.rs-40198. doi: 10.21203/rs.3.rs-40198/v1. Res Sq. 2020. Update in: Nat Commun. 2020 Nov 30;11(1):6121. doi: 10.1038/s41467-020-19819-1. PMID: 32702732 Free PMC article. Updated. Preprint.
-
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.Nat Commun. 2020 Nov 30;11(1):6121. doi: 10.1038/s41467-020-19819-1. Nat Commun. 2020. PMID: 33257686 Free PMC article.
-
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11341-8. doi: 10.1073/pnas.93.21.11341. Proc Natl Acad Sci U S A. 1996. PMID: 8876137 Free PMC article. Review.
-
Recombinant vaccinia viruses. Design, generation, and isolation.Mol Biotechnol. 1999 Dec 15;13(3):223-45. doi: 10.1385/MB:13:3:223. Mol Biotechnol. 1999. PMID: 10934535
-
Reprint of: Coronavirus reverse genetic systems: infectious clones and replicons.Virus Res. 2014 Dec 19;194:67-75. doi: 10.1016/j.virusres.2014.09.006. Epub 2014 Sep 26. Virus Res. 2014. PMID: 25261606 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources